These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18704487)

  • 21. Genetic evidence for a predominant role of PI3Kbeta catalytic activity in ITAM- and integrin-mediated signaling in platelets.
    Canobbio I; Stefanini L; Cipolla L; Ciraolo E; Gruppi C; Balduini C; Hirsch E; Torti M
    Blood; 2009 Sep; 114(10):2193-6. PubMed ID: 19515725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets.
    Larson MK; Chen H; Kahn ML; Taylor AM; Fabre JE; Mortensen RM; Conley PB; Parise LV
    Blood; 2003 Feb; 101(4):1409-15. PubMed ID: 12393417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets.
    Dütting S; Vögtle T; Morowski M; Schiessl S; Schäfer CM; Watson SK; Hughes CE; Ackermann JA; Radtke D; Hermanns HM; Watson SP; Nitschke L; Nieswandt B
    Circ Res; 2014 Jan; 114(3):444-453. PubMed ID: 24265393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper), stimulates platelets by binding to α2β1 integrin and glycoprotein Ib, activating Syk and phospholipase Cγ 2, but does not involve the glycoprotein VI/Fc receptor γ chain collagen receptor.
    Navdaev A; Clemetson JM; Polgar J; Kehrel BE; Glauner M; Magnenat E; Wells TN; Clemetson KJ
    J Biol Chem; 2001 Jun; 276(24):20882-9. PubMed ID: 11287424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble fibrin causes an acquired platelet glycoprotein VI signaling defect: implications for coagulopathy.
    Lee MY; Verni CC; Herbig BA; Diamond SL
    J Thromb Haemost; 2017 Dec; 15(12):2396-2407. PubMed ID: 28981200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo.
    Alshahrani MM; Yang E; Yip J; Ghanem SS; Abdallah SL; deAngelis AM; O'Malley CJ; Moheimani F; Najjar SM; Jackson DE
    Blood; 2014 Oct; 124(15):2431-41. PubMed ID: 25085348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin-9 activates platelet ITAM receptors glycoprotein VI and C-type lectin-like receptor-2.
    Zhi Z; Jooss NJ; Sun Y; Colicchia M; Slater A; Moran LA; Cheung HYF; Di Y; Rayes J; Poulter NS; Watson SP; Iqbal AJ
    J Thromb Haemost; 2022 Apr; 20(4):936-950. PubMed ID: 34936188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RhoG protein regulates glycoprotein VI-Fc receptor γ-chain complex-mediated platelet activation and thrombus formation.
    Kim S; Dangelmaier C; Bhavanasi D; Meng S; Wang H; Goldfinger LE; Kunapuli SP
    J Biol Chem; 2013 Nov; 288(47):34230-34238. PubMed ID: 24106269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation.
    Gilio K; Munnix IC; Mangin P; Cosemans JM; Feijge MA; van der Meijden PE; Olieslagers S; Chrzanowska-Wodnicka MB; Lillian R; Schoenwaelder S; Koyasu S; Sage SO; Jackson SP; Heemskerk JW
    J Biol Chem; 2009 Dec; 284(49):33750-62. PubMed ID: 19815551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxepin inhibits GPVI-dependent platelet Ca
    Geue S; Walker-Allgaier B; Eißler D; Tegtmeyer R; Schaub M; Lang F; Gawaz M; Borst O; Münzer P
    Am J Physiol Cell Physiol; 2017 Jun; 312(6):C765-C774. PubMed ID: 28404545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development.
    Lee RH; Bergmeier W
    J Thromb Haemost; 2016 Apr; 14(4):645-54. PubMed ID: 26749528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bruton's Tyrosine Kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints.
    Hsu J; Gu Y; Tan SL; Narula S; DeMartino JA; Liao C
    Immunol Lett; 2013 Feb; 150(1-2):97-104. PubMed ID: 23266841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen.
    Pearce AC; Senis YA; Billadeau DD; Turner M; Watson SP; Vigorito E
    J Biol Chem; 2004 Dec; 279(52):53955-62. PubMed ID: 15456756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feedback Regulation of Syk by Protein Kinase C in Human Platelets.
    Makhoul S; Dorschel S; Gambaryan S; Walter U; Jurk K
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: comparison with those of glycoprotein VI.
    Inoue K; Ozaki Y; Satoh K; Wu Y; Yatomi Y; Shin Y; Morita T
    Biochem Biophys Res Commun; 1999 Mar; 256(1):114-20. PubMed ID: 10066433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverging signaling events control the pathway of GPVI down-regulation in vivo.
    Rabie T; Varga-Szabo D; Bender M; Pozgaj R; Lanza F; Saito T; Watson SP; Nieswandt B
    Blood; 2007 Jul; 110(2):529-35. PubMed ID: 17374738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity.
    Nonne C; Lenain N; Hechler B; Mangin P; Cazenave JP; Gachet C; Lanza F
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1293-8. PubMed ID: 15774906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet action of indirubin-3'-monoxime through suppression of glycoprotein VI-mediated signal transduction: a possible role for ERK signaling in platelets.
    Lee JJ; Han JH; Jung SH; Lee SG; Kim IS; Cuong NM; Huong TT; Khanh PN; Kim YH; Yun YP; Ma JY; Myung CS
    Vascul Pharmacol; 2014 Dec; 63(3):182-92. PubMed ID: 25451564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of neonatal platelet adhesion, activation, and aggregation.
    Baker-Groberg SM; Lattimore S; Recht M; McCarty OJ; Haley KM
    J Thromb Haemost; 2016 Apr; 14(4):815-27. PubMed ID: 26806373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.